Alliancebernstein L.P. Invests $183,000 in Capricor Therapeutics Inc (NASDAQ:CAPR)
Alliancebernstein L.P. bought a new stake in Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought 13,280 shares of the biotechnology company’s stock, valued at approximately $183,000. Several other large investors have also modified their holdings of CAPR. Vanguard Group Inc. grew its stake in shares of Capricor […]
Alliancebernstein L.P. bought a new stake in Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought 13,280 shares of the biotechnology company’s stock, valued at approximately $183,000. Several other large investors have also modified their holdings of CAPR. Vanguard Group Inc. grew its stake in shares of Capricor […]
